Incidental Mutation 'IGL02371:Fbxo32'
ID 290949
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Fbxo32
Ensembl Gene ENSMUSG00000022358
Gene Name F-box protein 32
Synonyms atrogin-1, ATROGIN1, MAFbx, 4833442G10Rik
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # IGL02371
Quality Score
Status
Chromosome 15
Chromosomal Location 58039275-58078288 bp(-) (GRCm39)
Type of Mutation utr 3 prime
DNA Base Change (assembly) A to T at 58044860 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000022986 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000022986]
AlphaFold Q9CPU7
Predicted Effect probably benign
Transcript: ENSMUST00000022986
SMART Domains Protein: ENSMUSP00000022986
Gene: ENSMUSG00000022358

DomainStartEndE-ValueType
Blast:FBOX 228 269 6e-16 BLAST
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and contains an F-box domain. This protein is highly expressed during muscle atrophy, whereas mice deficient in this gene were found to be resistant to atrophy. This protein is thus a potential drug target for the treatment of muscle atrophy. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]
PHENOTYPE: A targeted homozygous mutation in this gene results in resistance to skeletal muscle atrophy in response to nerve injury. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 31 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Arfgef3 T C 10: 18,522,287 (GRCm39) T580A probably benign Het
Casp2 T A 6: 42,244,902 (GRCm39) D100E probably benign Het
Cd1d1 C A 3: 86,906,188 (GRCm39) R29L probably benign Het
Cdc45 C T 16: 18,617,479 (GRCm39) M200I probably benign Het
Cyct A G 2: 76,184,434 (GRCm39) *106R probably null Het
Enam A G 5: 88,650,668 (GRCm39) I726V probably benign Het
Epha3 T G 16: 63,405,383 (GRCm39) probably null Het
Erbb4 T C 1: 68,329,453 (GRCm39) D632G probably benign Het
Fam217a T C 13: 35,095,384 (GRCm39) N125S possibly damaging Het
Foxa1 T C 12: 57,589,486 (GRCm39) T245A probably damaging Het
Gars1 T C 6: 55,042,452 (GRCm39) V395A probably benign Het
Gimap5 A T 6: 48,729,937 (GRCm39) N169I probably damaging Het
Itgav A G 2: 83,600,397 (GRCm39) M266V probably damaging Het
Klhl14 G A 18: 21,785,238 (GRCm39) S63F probably damaging Het
Lpp G A 16: 24,580,361 (GRCm39) A26T probably damaging Het
Lrrc17 T C 5: 21,765,994 (GRCm39) Y159H probably damaging Het
Lzts1 A T 8: 69,591,450 (GRCm39) S233T probably damaging Het
Mdn1 T C 4: 32,676,860 (GRCm39) probably benign Het
Nrf1 A T 6: 30,118,990 (GRCm39) I382F possibly damaging Het
Or11i1 A T 3: 106,729,362 (GRCm39) F171Y probably damaging Het
Or1m1 G T 9: 18,666,000 (GRCm39) S310R probably benign Het
Or4k41 A G 2: 111,280,354 (GRCm39) R290G probably damaging Het
Pde9a T A 17: 31,639,259 (GRCm39) V63D possibly damaging Het
Plcg1 T A 2: 160,595,427 (GRCm39) N484K probably damaging Het
Plekhg4 T A 8: 106,105,691 (GRCm39) probably null Het
Pot1b A G 17: 56,002,092 (GRCm39) Y161H possibly damaging Het
Ptchd4 G A 17: 42,627,865 (GRCm39) G109S possibly damaging Het
Rad51ap1 T C 6: 126,904,527 (GRCm39) N119S probably benign Het
Rbm22 C T 18: 60,705,028 (GRCm39) probably benign Het
Stk36 T A 1: 74,661,414 (GRCm39) S480R probably benign Het
Ugt2b5 A T 5: 87,275,535 (GRCm39) probably null Het
Other mutations in Fbxo32
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01584:Fbxo32 APN 15 58,047,632 (GRCm39) missense probably damaging 0.98
IGL02721:Fbxo32 APN 15 58,046,358 (GRCm39) missense possibly damaging 0.85
R0277:Fbxo32 UTSW 15 58,047,605 (GRCm39) missense probably damaging 1.00
R0323:Fbxo32 UTSW 15 58,047,605 (GRCm39) missense probably damaging 1.00
R1661:Fbxo32 UTSW 15 58,054,865 (GRCm39) missense probably damaging 1.00
R2315:Fbxo32 UTSW 15 58,071,431 (GRCm39) missense probably benign 0.28
R2321:Fbxo32 UTSW 15 58,054,689 (GRCm39) missense possibly damaging 0.52
R2849:Fbxo32 UTSW 15 58,071,368 (GRCm39) missense probably benign
R4233:Fbxo32 UTSW 15 58,055,729 (GRCm39) missense possibly damaging 0.81
R4569:Fbxo32 UTSW 15 58,044,873 (GRCm39) missense probably damaging 0.99
R6856:Fbxo32 UTSW 15 58,078,037 (GRCm39) start gained probably benign
R7747:Fbxo32 UTSW 15 58,054,757 (GRCm39) missense probably damaging 1.00
R7868:Fbxo32 UTSW 15 58,077,986 (GRCm39) missense probably damaging 1.00
R8317:Fbxo32 UTSW 15 58,068,626 (GRCm39) missense probably damaging 1.00
R9009:Fbxo32 UTSW 15 58,046,358 (GRCm39) missense possibly damaging 0.85
Z1176:Fbxo32 UTSW 15 58,068,638 (GRCm39) missense probably damaging 1.00
Posted On 2015-04-16